196 related articles for article (PubMed ID: 28836544)
1. Multidrug-resistant Tuberculosis Burden among the New Tuberculosis Patients in Zhejiang Province: An Observational Study, 2009-2013.
Peng Y; Chen SH; Zhang L; Chen B; Zhang MW; He TN; Wang F; Chai CL; Zhou L; Zhang Y; Wang XM; Jia Z
Chin Med J (Engl); 2017 Sep; 130(17):2021-2026. PubMed ID: 28836544
[TBL] [Abstract][Full Text] [Related]
2. Factors contributing to the high prevalence of multidrug-resistant tuberculosis: a study from China.
Liang L; Wu Q; Gao L; Hao Y; Liu C; Xie Y; Sun H; Yan X; Li F; Li H; Fang H; Ning N; Cui Y; Han L
Thorax; 2012 Jul; 67(7):632-8. PubMed ID: 22403070
[TBL] [Abstract][Full Text] [Related]
3. Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan.
van den Hof S; Tursynbayeva A; Abildaev T; Adenov M; Pak S; Bekembayeva G; Ismailov S
Int J Tuberc Lung Dis; 2013 Apr; 17(4):526-31. PubMed ID: 23485387
[TBL] [Abstract][Full Text] [Related]
4. Drug-resistant tuberculosis in Zhejiang Province, China: an updated analysis of time trends, 1999-2013.
Wu B; Zhang L; Liu Z; He H; Pan A; Wang F; Zhang M; Chen B; Lu Z; Chen S; Wang X
Glob Health Action; 2017; 10(1):1293925. PubMed ID: 28578621
[TBL] [Abstract][Full Text] [Related]
5. Management of pediatric multidrug-resistant tuberculosis and latent tuberculosis infections in New York City from 1995 to 2003.
Feja K; McNelley E; Tran CS; Burzynski J; Saiman L
Pediatr Infect Dis J; 2008 Oct; 27(10):907-12. PubMed ID: 18756183
[TBL] [Abstract][Full Text] [Related]
6. Trends and characteristics of drug-resistant tuberculosis in rural Shandong, China.
Tao NN; He XC; Zhang XX; Liu Y; Yu CB; Li HC
Int J Infect Dis; 2017 Dec; 65():8-14. PubMed ID: 28958922
[TBL] [Abstract][Full Text] [Related]
7. Drug-resistant tuberculosis in Zhejiang Province, China, 1999-2008.
Wang X; Fu Q; Li Z; Chen S; Liu Z; Nelson H; Yang Q; Jia Z; Dye C
Emerg Infect Dis; 2012 Mar; 18(3):496-8. PubMed ID: 22377167
[TBL] [Abstract][Full Text] [Related]
8. Additional Drug Resistance in Patients with Multidrug-resistant Tuberculosis in Korea: a Multicenter Study from 2010 to 2019.
Lee T; Lee SJ; Jeon D; Lee HY; Kim HJ; Kang BH; Mok J
J Korean Med Sci; 2021 Jul; 36(26):e174. PubMed ID: 34227261
[TBL] [Abstract][Full Text] [Related]
9. Risk factors associated with fluoroquinolone-resistant tuberculosis in a Beijing tuberculosis referral hospital.
Liu CH; Yang N; Wang Q; Hu YL; Li L; Zhang GY; Zhu B
Respirology; 2011 Aug; 16(6):918-25. PubMed ID: 21564401
[TBL] [Abstract][Full Text] [Related]
10. Drug resistance among tuberculosis cases in the European Union and European Economic Area, 2007 to 2012.
van der Werf MJ; Ködmön C; Hollo V; Sandgren A; Zucs P
Euro Surveill; 2014 Mar; 19(10):. PubMed ID: 24650865
[TBL] [Abstract][Full Text] [Related]
11. Estimating the global burden of multidrug-resistant tuberculosis among prevalent cases of tuberculosis.
Nourzad S; Jenkins HE; Milstein M; Mitnick CD
Int J Tuberc Lung Dis; 2017 Jan; 21(1):6-11. PubMed ID: 28157458
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal Analysis of Prevalence and Risk Factors of Rifampicin-Resistant Tuberculosis in Zhejiang, China.
Liu Z; Zhang M; Wang J; Chen S; Wu B; Zhou L; Pan A; Wang W; Wang X
Biomed Res Int; 2020; 2020():3159482. PubMed ID: 32104686
[TBL] [Abstract][Full Text] [Related]
13. Additional Drug Resistance Patterns among Multidrug-Resistant Tuberculosis Patients in Korea: Implications for Regimen Design.
Mok JH; Kang BH; Lee T; Lee HK; Jang HJ; Cho YJ; Jeon D
J Korean Med Sci; 2017 Apr; 32(4):636-641. PubMed ID: 28244290
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for multidrug-resistant tuberculosis in Hong Kong.
Law WS; Yew WW; Chiu Leung C; Kam KM; Tam CM; Chan CK; Leung CC
Int J Tuberc Lung Dis; 2008 Sep; 12(9):1065-70. PubMed ID: 18713506
[TBL] [Abstract][Full Text] [Related]
15. The burden of MDR/XDR tuberculosis in coastal plains population of China.
Yang X; Yuan Y; Pang Y; Wang B; Bai Y; Wang Y; Yu B; Zhang Z; Fan M; Zhao Y
PLoS One; 2015; 10(2):e0117361. PubMed ID: 25689373
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for multidrug resistance among previously treated patients with tuberculosis in eastern China: a case-control study.
Chen S; Huai P; Wang X; Zhong J; Wang X; Wang K; Wang L; Jiang S; Li J; Peng Y; Ma W
Int J Infect Dis; 2013 Dec; 17(12):e1116-20. PubMed ID: 23916547
[TBL] [Abstract][Full Text] [Related]
17. Extensively drug-resistant tuberculosis in the United States, 1993-2007.
Shah NS; Pratt R; Armstrong L; Robison V; Castro KG; Cegielski JP
JAMA; 2008 Nov; 300(18):2153-60. PubMed ID: 19001626
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and risk factors of multi-drug resistant tuberculosis in Dalian, China.
Lv XT; Lu XW; Shi XY; Zhou L
J Int Med Res; 2017 Dec; 45(6):1779-1786. PubMed ID: 28345426
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for diagnosis and treatment delay among patients with multidrug-resistant tuberculosis in Hunan Province, China.
Akalu TY; Clements ACA; Gebreyohannes EA; Xu Z; Bai L; Alene KA
BMC Infect Dis; 2024 Feb; 24(1):159. PubMed ID: 38308252
[TBL] [Abstract][Full Text] [Related]
20. Retrospective analysis of multidrug-resistant tuberculosis case notifications in Australia (1999-2018).
Camphor HS; Viney K; Polkinghorne B; Pennington K
Commun Dis Intell (2018); 2020 Aug; 44():. PubMed ID: 32829704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
